Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Early-onset vs. Late-onset Parkinson’s disease: A Clinical-pathological Study
Leslie W. Ferguson, Ali H. Rajput, Alexander Rajput
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques (2015) Vol. 43, Iss. 1, pp. 113-119
Open Access | Times Cited: 94

Showing 1-25 of 94 citing articles:

An update on the diagnosis and treatment of Parkinson disease
Philippe Rizek, Niraj Kumar, Mandar Jog
Canadian Medical Association Journal (2016) Vol. 188, Iss. 16, pp. 1157-1165
Open Access | Times Cited: 381
Gut microbiota in patients with Parkinson's disease in southern China
Aiqun Lin, Wenxia Zheng, Yan He, et al.
Parkinsonism & Related Disorders (2018) Vol. 53, pp. 82-88
Closed Access | Times Cited: 219
The role of CD56bright NK cells in neurodegenerative disorders
Carla Rodriguez-Mogeda, Chaja M. J. van Ansenwoude, Lennart van der Molen, et al.
Journal of Neuroinflammation (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 13
A Practical Approach to Early-Onset Parkinsonism
Giulietta Riboldi, Emanuele Frattini, Edoardo Monfrini, et al.
Journal of Parkinson s Disease (2021) Vol. 12, Iss. 1, pp. 1-26
Open Access | Times Cited: 45
MRI data-driven clustering reveals different subtypes of Dementia with Lewy bodies
Anna Inguanzo, Konstantinos Poulakis, Rosaleena Mohanty, et al.
npj Parkinson s Disease (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 17
MicroRNAs and Target Genes As Biomarkers for the Diagnosis of Early Onset of Parkinson Disease
Ahmad Rasyadan Arshad, Siti Aishah Sulaiman, Amalia Afzan Saperi, et al.
Frontiers in Molecular Neuroscience (2017) Vol. 10
Open Access | Times Cited: 53
PERFIL EPIDEMIOLÓGICO DOS PACIENTES INTERNADOS POR DOENÇA DE PARKINSON NO BRASIL NO ANO DE 2020
Mateus Andrade Ferreira, Caio Victor Queiroga Barreto, Francisco Samuel Estrela Dantas, et al.
Revista interdisciplinar em saúde (2022) Vol. 9, Iss. Único, pp. 136-147
Open Access | Times Cited: 26
Evaluating the Role of SNCA, LRRK2, and GBA in Chinese Patients With Early‐Onset Parkinson's Disease
Yongping Chen, Xiaojing Gu, Ruwei Ou, et al.
Movement Disorders (2020) Vol. 35, Iss. 11, pp. 2046-2055
Closed Access | Times Cited: 39
Occupational pesticide exposure and the risk of death in patients with Parkinson’s disease: an observational study in southern Brazil
Márcio Schneider Medeiros, Sumanth Reddy, Mariana P. Socal, et al.
Environmental Health (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 37
The long-term trend of Parkinson’s disease incidence and mortality in China and a Bayesian projection from 2020 to 2030
Fangyao Chen, Shiyu Chen, Aima Si, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 21
Age at Onset Influences Progression of Motor and Non-Motor Symptoms during the Early Stage of Parkinson’s Disease: A Monocentric Retrospective Study
Lanfranco De Carolis, Silvia Galli, Edoardo Bianchini, et al.
Brain Sciences (2023) Vol. 13, Iss. 2, pp. 157-157
Open Access | Times Cited: 11
Pediatric-onset PRKN disease: New insights into an understudied population
Özge Gönül Öner, C Bruneau, Valérie Fraix, et al.
Journal of Parkinson s Disease (2025)
Open Access
Dabigatran Combined With Benztropine Ameliorates Cobalt Chloride-Induced Parkinsonism in Rats, Restores Protease-Activated Receptor 1 (PAR1), and Mitigates Oxidative Stress
Sherine Abdelmissih, Laila A. Rashed, Mohamed Sharif Ismail Negm, et al.
Cureus (2025)
Open Access
Therapy-resistant symptoms in Parkinson’s disease
Ruxandra Julia Vorovenci, Roberta Biundo, Angelo Antonini
Journal of Neural Transmission (2015) Vol. 123, Iss. 1, pp. 19-30
Closed Access | Times Cited: 34
Age at onset as stratifier in idiopathic Parkinson’s disease – effect of ageing and polygenic risk score on clinical phenotypes
Lukas Pavelka, Armin Rauschenberger, Zied Landoulsi, et al.
npj Parkinson s Disease (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 18
ADHD and Neurodegenerative Disease Risk: A Critical Examination of the Evidence
Sara Becker, Manu J. Sharma, Brandy L. Callahan
Frontiers in Aging Neuroscience (2022) Vol. 13
Open Access | Times Cited: 16
Externally validated deep learning model to identify prodromal Parkinson’s disease from electrocardiogram
İbrahi̇m Karabayir, Fatma Gunturkun, Liam Butler, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 10
Patterns of striatal functional connectivity differ in early and late onset Parkinson’s disease
Yanbing Hou, Jing Yang, Chunyan Luo, et al.
Journal of Neurology (2016) Vol. 263, Iss. 10, pp. 1993-2003
Closed Access | Times Cited: 29
Brain Mitochondrial Impairment in Early‐Onset Parkinson's Disease With or Without PINK1 Mutation
Mario Rango, Gabriele Dossi, Letizia Squarcina, et al.
Movement Disorders (2020) Vol. 35, Iss. 3, pp. 504-507
Closed Access | Times Cited: 26
A pathophysiological model of gait captures the details of the impairment of pace/rhythm, variability and asymmetry in Parkinsonian patients at distinct stages of the disease
Marco Godi, Ilaria Arcolin, Marica Giardini, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 22
The relationship between environmental factors and different Parkinson's disease subtypes in Greece: Data analysis of the Hellenic Biobank of Parkinson's disease
Efthalia Angelopoulou, Maria Bozi, Athina‐Maria Simitsi, et al.
Parkinsonism & Related Disorders (2019) Vol. 67, pp. 105-112
Closed Access | Times Cited: 22
Real-world pharmacological treatment patterns of patients with young-onset Parkinson’s disease in Japan: a medical claims database analysis
Sachiko Kasamo, Masato Takeuchi, Masashi Ikuno, et al.
Journal of Neurology (2019) Vol. 266, Iss. 8, pp. 1944-1952
Closed Access | Times Cited: 21
The ADORA1 mutation linked to early-onset Parkinson’s disease alters adenosine A1-A2A receptor heteromer formation and function
Laura I. Sarasola, Claudia Llinás del Torrent, Andrea Pérez Arévalo, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 156, pp. 113896-113896
Open Access | Times Cited: 11
The Risk Factors for the Wearing-off Phenomenon in Parkinson's Disease in Japan: A Cross-sectional, Multicenter Study
Shinji Ouma, Jiro Fukae, Shinsuke Fujioka, et al.
Internal Medicine (2017) Vol. 56, Iss. 15, pp. 1961-1966
Open Access | Times Cited: 21
The neuroinflammatory role of glucocerebrosidase in Parkinson's disease
Ruxue Bo, Yanyan Li, Tian-Tian Zhou, et al.
Neuropharmacology (2022) Vol. 207, pp. 108964-108964
Closed Access | Times Cited: 10
Page 1 - Next Page

Scroll to top